Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Am J Transplant. 2018 Oct 1;19(2):324–330. doi: 10.1111/ajt.15086

Table 2.

Adverse Events in Tolerance Induction Regimens

Medical Center
Patients and Adverse Events Northwestern
University*
Stanford University Massachussetts
General
Hospital
Samsung
Medical
Center
HLA matched or mismatched mismatched matched/mismatched mismatched mismatched
No. patients given transplants 37 29/19 10 7
No. with BK
viremia/nephropathy
ND** 0/0 0 7
No. with GVHD 2 0/0 0 0
No. with engraftment syndrome 0 0/2 9 2
No. with graft loss
(rejection/disease
relapse/infection)
2*** 2/0 3 1***
No. of deaths 1 3/0 0 0
*

One of 37 recipients was enrolle and transplanted at Duke University

**

ND-not discussed

***

graft loss due to infection